Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 14
Phase 21

Trial Status

Completed4
Other1

Role Distribution

Principal Investigator1
Other Roles4
PI Rate20%

Activity Timeline

Clinical Trials (5)

NCT04884399Phase 1Completed
Phase I Study to Compare CMAB818 Injection and Lucentis® in Patients With Wet AMD
Wet Age-related Macular Degeneration
StudychairStart date: 2021-06-03
NCT03967548Phase 1Completed
The Germinal Peptide Eye Drops in Healthy Volunteers in a Clinical Study
Corneal Defect
StudydirectorStart date: 2021-04-09
NCT03504475Phase 1Completed
Bioequivalence Study of Paroxetine Tablets and Paxil® Under Fasting and Fed Conditions in Chinese Healthy Volunteers
Generalized Anxiety DisorderMajor Depressive DisorderObsessive-Compulsive Disorder+2 more
PrincipalinvestigatorStart date: 2018-03-29

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Wenbin Wei, PhD

Beijing Tongren Hospital

Related
1 trials

Shared therapeutic areas:

Wet Age-Related Macular Degeneration

Worked with same sponsors:

Shanghai Biomabs Pharmaceutical Co., Ltd.
Collaborated on 1 trial
Similarity Score14%

Yair bAR-hAIM, PhD

Tel Aviv University

Related
18 trials

Shared therapeutic areas:

Phobia, SocialMajor Depressive DisorderGeneralized Anxiety Disorder
Similarity Score13%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

Major Depressive DisorderObsessive-Compulsive DisorderGeneralized Anxiety Disorder
Similarity Score13%

Herbert Ward, MD

University of Florida

Related
2 trials

Shared therapeutic areas:

Major Depressive DisorderObsessive-Compulsive Disorder
Similarity Score9%

Francisco Moreno, MD

University of Arizona

Related
2 trials

Shared therapeutic areas:

Major Depressive DisorderObsessive-Compulsive Disorder
Similarity Score9%

Gerhard Andersson, Professor

Linkoeping University

Related
12 trials

Shared therapeutic areas:

Generalized Anxiety DisorderPhobia, Social
Similarity Score9%

Project Leader

Ono Pharmaceutical Co., Ltd.

Related
47 trials

Shared therapeutic areas:

Major Depressive DisorderPhobia, Social
Similarity Score9%

Michael B Gill

Power Life Sciences Inc.

Related
105 trials

Shared therapeutic areas:

Generalized Anxiety DisorderObsessive-Compulsive Disorder
Similarity Score9%

Hesheng Liu, Ph.D.

Changping Laboratory

Related
20 trials

Shared therapeutic areas:

Major Depressive DisorderObsessive-Compulsive Disorder
Similarity Score9%

Leighton Y. Huey, MD

UConn Health

Related
1 trials

Shared therapeutic areas:

Major Depressive Disorder
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT04884399Phase 1StudyChair

Phase I Study to Compare CMAB818 Injection and Lucentis® in Patients With Wet AMD

Wet Age-related Macular Degeneration
Completed
NCT03967548Phase 1StudyDirector

The Germinal Peptide Eye Drops in Healthy Volunteers in a Clinical Study

Corneal Defect
Completed
NCT04228926Phase 2StudyDirector

Evaluating the Efficacy and Safety of ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defects

Corneal Defect
Unknown
NCT03662971Phase 1StudyDirector

Evaluate the Tolerance, Safety and Pharmacokinetics of Germinal Peptide Eye Drops in Healthy Volunteers

Corneal Defect
Completed
NCT03504475Phase 1PrincipalInvestigator

Bioequivalence Study of Paroxetine Tablets and Paxil® Under Fasting and Fed Conditions in Chinese Healthy Volunteers

Generalized Anxiety DisorderMajor Depressive DisorderObsessive-Compulsive Disorder+2 more
Completed

All 5 trials loaded